Studies have found that METTL3 upregulates the m6A level of heparin binding growth factor (HDGF) mRNA, and then enhances its stability and promotes its expression through IGF2BP3, thereby increasing tumor angiogenesis and promoting gastric cancer metastasis (Wang et al., 2020). The gene discussed is METTL3; the disease is gastric cancer.